Akari Therapeutics
$1.999876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.02 (-1.01%) Today
+$0.02 (+1.02%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell AKTX and other stocks, options, ETFs, and crypto commission-free!
About AKTX
Akari Therapeutics Plc ADR, also called Akari Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. Read More The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.
Employees
14
Headquarters
London, London & South East
Founded
2004
Market Cap
41.81M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
102.07K
High Today
$1.98
Low Today
$1.92
Open Price
$1.97
Volume
94.67K
52 Week High
$9.20
52 Week Low
$1.61
Collections
AKTX Earnings
-$0.47
-$0.31
-$0.16
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Apr 21, After Hours
People Also Bought
Viking Therapeutics
38,970
$6.92
-0.57%Verastem
17,567
$2.22
+5.71%Atossa Therapeutics
4,123
$1.34
-4.29%FuelCell Energy
53,461
$2.51
-3.83%BioPharmX
18,004
$0.38
+1.09%Sorrento Therapeutics
12,132
$2.66
+0.38%Geron
31,562
$1.26
-1.56%NIO
127,912
$4.09
-3.99%Proteostasis Therapeutics
3,572
$1.93
-2.53%Aurora Cannabis
671,520
$1.67
-0.60%Advaxis
11,018
$0.98
-3.92%Titan Pharmaceuticals
19,361